Mike Gabrin

Title: Mike Gabrin: Innovator in Cancer Treatment

Introduction

Mike Gabrin is a notable inventor based in Pittsburgh, PA, who has made significant contributions to the field of cancer treatment. His innovative approach focuses on individualizing chemotherapy to improve patient outcomes. With one patent to his name, Gabrin is dedicated to advancing medical science through his research and inventions.

Latest Patents

Gabrin's patent, titled "Methods for selecting active agents for cancer treatment," provides groundbreaking methods for individualizing chemotherapy. This invention aims to predict a cancer patient's response to neoadjuvant chemotherapy by assessing the probability of a positive response to candidate agents prior to surgery. The methods involve culturing malignant cells from a patient's biopsy specimen and testing these cells for resistance or sensitivity to various candidate agents. Additionally, the invention includes methods for accurately scoring and interpreting assay results, which can predict a patient's pathological complete response (pCR) to the corresponding treatment regimen.

Career Highlights

Mike Gabrin is currently associated with Precision Therapeutics, Inc., where he continues to work on innovative solutions for cancer treatment. His dedication to research and development has positioned him as a key figure in the medical community, particularly in the realm of personalized medicine.

Collaborations

Gabrin collaborates with talented individuals such as Zhibao Mi and Dave Gingrich, who contribute to the advancement of his research and the development of new therapeutic methods.

Conclusion

Mike Gabrin's work in individualizing chemotherapy represents a significant advancement in cancer treatment. His innovative methods have the potential to improve patient outcomes and revolutionize the way cancer is treated.